Prednisone clinical trials
Also written Deltasone, DeCortin and NSC-10023.
Includes 3 studies of Prednisone acetate.
Related medicines add 2 studies
Counted the way a researcher would: Prednisone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Prednisone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Prednisone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 21 Feb 1955 · METICORTEN · NDA 009766 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- NSC-10023
- 3
Studies by the year they started
541 studies that test it; most in 2013 (27); 2 more planned to start later
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1992 | 1 |
| 1993 | 3 |
| 1994 | 2 |
| 1995 | 4 |
| 1996 | 3 |
| 1997 | 4 |
| 1998 | 8 |
| 1999 | 9 |
| 2000 | 8 |
| 2001 | 6 |
| 2002 | 16 |
| 2003 | 8 |
| 2004 | 21 |
| 2005 | 20 |
| 2006 | 16 |
| 2007 | 22 |
| 2008 | 16 |
| 2009 | 24 |
| 2010 | 15 |
| 2011 | 25 |
| 2012 | 21 |
| 2013 | 27 |
| 2014 | 20 |
| 2015 | 13 |
| 2016 | 25 |
| 2017 | 23 |
| 2018 | 22 |
| 2019 | 19 |
| 2020 | 27 |
| 2021 | 19 |
| 2022 | 15 |
| 2023 | 25 |
| 2024 | 14 |
| 2025 | 16 |
| 2026 | 23 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 66 · Other 481
National Cancer Institute (NCI) (26) · M.D. Anderson Cancer Center (15) · St. Jude Children's Research Hospital (11) · Children's Oncology Group (11) · Mayo Clinic (9) · Assistance Publique - Hôpitaux de Paris (9) · SWOG Cancer Research Network (9) · University of Washington (7)
Often tested with
Tested in the same studies.
Cyclophosphamide (150) · Vincristine (122) · Doxorubicin (105) · Rituximab (64) · Etoposide (58) · Dexamethasone (46) · Methotrexate (43) · Abiraterone (36)
Related medicines
As reviewed, each with the page that says it.
- One of Corticosteroids source
- One of Glucocorticoid source
- One of Steroids source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 24 phase 3 studies under way
Prednisone is the comparator. A study of two new drugs counts under both.
- 3Lenalidomide · The Lymphoma Academic Research Organisation, Ruijin Hospital · next primary completion Jul 2028
- 2Cytarabine · National Cancer Institute (NCI), The Affiliated People's Hospital of Ningbo University · next primary completion Jul 2028
- 2Dexamethasone · National Cancer Institute (NCI), University of Cologne · next primary completion Jul 2028
- 2Axicabtagene ciloleucel · Kite, A Gilead Company · next primary completion Oct 2030
- 1Blinatumomab · National Cancer Institute (NCI) · next primary completion Jul 2028
- 1Cyclophosphamide · National Cancer Institute (NCI) · next primary completion Jul 2028
- 1Doxorubicin · National Cancer Institute (NCI) · next primary completion Jul 2028
- 1Mesna · National Cancer Institute (NCI) · next primary completion Jul 2028
Reaching primary completion within a year · 35, 6 in phase 3
Studies that test Prednisone, phase 3 first.
- Dec 2026ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate CancerPhase 3 · Karolinska Institutet
- Dec 2026Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)Phase 3 · Children's Cancer Group, China
- Jun 2027A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)Phase 3 · Genmab
- Jun 2027Severe Erythema Multiforme - CORTICOPhase 3 · Assistance Publique - Hôpitaux de Paris
- Sep 2027A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaPhase 3 · National Cancer Institute (NCI)
- Oct 2027PPI Versus Histamine Antagnists as Adjuvant to ChemotherapyPhase 3 · Sherief Abd-Elsalam
- Nov 2026Corticosteroid Effect on Achalasia Variant EGJOOEarly Phase 1 · Baylor Research Institute
- Nov 2026Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate CancerPhase 2 · University of California, Davis
- Nov 2026Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal FibrosisPhase 4 · Assistance Publique - Hôpitaux de Paris
- Dec 2026A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate CancerPhase 1/2 · Jiangsu HengRui Medicine Co., Ltd.
Studies
Open first, then newest update. How each study uses Prednisone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 547
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabRecruitingPhase 3National Cancer Institute (NCI)NCT05675410Written as Prednisone
- Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell LymphomaRecruitingPhase 1/2National Cancer Institute (NCI)NCT03223610Written as Prednisone
- Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell LymphomaRecruitingPhase 2National Cancer Institute (NCI)NCT06649812Written as Prednisone
- Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell LymphomaRecruitingPhase 2National Cancer Institute (NCI)NCT04002947Written as CHOP
- Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant RecipientsNot yet recruitingEarly Phase 1Virginia Commonwealth UniversityNCT07806136Written as Prednisone (SOC arm)
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutRecruitingPhase 4Massachusetts General HospitalNCT04875702Written as Prednisone 40 mg
- MK-2870-U01 Substudy 1: A Clinical Trial of Sacituzumab Tirumotecan to Treat Prostate Cancer (MK-2870-01A)Not yet recruitingPhase 1/2Merck Sharp & Dohme LLCNCT07908524Written as Prednisone
- Efficacy and Safety of Polatuzumab Vedotin, Rituximab Combined With Reduced-dose Cyclophosphamide, Doxorubicin and Prednisone Regimen in the Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma: A Multicenter, Single-arm, Prospective StudyRecruitingPhase 4The First Hospital of Jilin UniversityNCT07908888Written as Prednisone
- Molecular Evidence of Rejection Intervention TrialNot yet recruitingNot applicableCareDxNCT07905599Written as Prednisone
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruitingPhase 2National Cancer Institute (NCI)NCT06317662Written as Prednisone
- Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin LymphomaRecruitingPhase 2University of WashingtonNCT07097363Written as Prednisone
- Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate CancerRecruitingPhase 2University of NebraskaNCT07237269Written as Prednisone
- A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaRecruitingPhase 2University of Michigan Rogel Cancer CenterNCT05901519Written as Prednisone
- Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerRecruitingPhase 1/2National Cancer Institute (NCI)NCT05896839Written as Prednisone
- A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell LymphomaRecruitingPhase 2University of RochesterNCT03758989Written as Prednisone
- Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)RecruitingPhase 2Mayo ClinicNCT06676579Written as Prednisone
- ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months.Not yet recruitingPhase 3Starship Child Health, Te Toka Tumai AucklandNCT07830108Written as Prednisone or Prednisolone
- Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis PlaquesRecruitingPhase 2National Institute of Neurological Disorders and Stroke (NINDS)NCT02784210Written as Prednisone
- Post-op Prednisone and Glucose Monitoring in TKARecruitingPhase 4Columbia UniversityNCT07630896Written as Prednisone
- Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene VariantsNot yet recruitingPhase 2Assistance Publique - Hôpitaux de ParisNCT07443436Written as Prednisone 10 mg/day
See all 547 studies that test Prednisone →
Given beside what is tested · 708 — Prednisone is usual care or a partner of the new treatment
- Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06136624Written as Prednisone
- A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)RecruitingPhase 2Merck Sharp & Dohme LLCNCT06890884Written as Prednisone
- A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06717347Written as Prednisone
- TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)RecruitingPhase 1/2Novartis PharmaceuticalsNCT07190300Written as Prednisone/Prednisolone
- A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)RecruitingPhase 2/3Merck Sharp & Dohme LLCNCT07634471Written as Prednisone
- Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)RecruitingPhase 1National Cancer Institute (NCI)NCT04301076Written as Prednisone
- A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma GangrenosumRecruitingPhase 3LEO PharmaNCT06624670Written as Prednisone
- Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell LymphomasRecruitingPhase 1City of Hope Medical CenterNCT07278856Written as Prednisone
- Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell LymphomaNot yet recruitingPhase 1National Cancer Institute (NCI)NCT07444710Written as Prednisone
- The CARDIOPROTECT TrialNot yet recruitingPhase 2Beth Israel Deaconess Medical CenterNCT07654426Written as Prednisone
- Venetoclax Plus Inotuzumab Reduced-Intensity Induction Sequentially Followed by Blinatumomab in B-ALLNot yet recruitingNot applicableInstitute of Hematology & Blood Diseases Hospital, ChinaNCT07921550Written as Prednisone
- AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")RecruitingPhase 1National Cancer Institute (NCI)NCT07649304Written as Prednisone
- A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaRecruitingPhase 3Regeneron PharmaceuticalsNCT06091865Written as Prednisone/Prednisolone
- A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative StudyRecruitingPhase 2M.D. Anderson Cancer CenterNCT06630091Written as Prednisone
- Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaRecruitingPhase 2Alliance for Clinical Trials in OncologyNCT04803201Written as Prednisone
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsRecruitingPhase 2Hoffmann-La RocheNCT05039619Written as Prednisone
- A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate CancerRecruitingPhase 1Janssen Research & Development, LLCNCT05818683Written as Abiraterone acetate plus prednisone (AAP)
- A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)RecruitingPhase 3Janssen Research & Development, LLCNCT06533098Written as Prednisone
- A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid MalignanciesRecruitingPhase 1Janssen Research & Development, LLCNCT07308132Written as Prednisone
- A Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell Lymphoma With IPI Score 2 to 5Not yet recruitingPhase 3AstraZenecaNCT07911553Written as Prednisone
Showing 20 of 708.
As the comparator · 113 — what is tested is compared with Prednisone
- A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular LymphomaRecruitingPhase 3Regeneron PharmaceuticalsNCT06091254Written as Prednisone/prednisolone
- A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerRecruitingPhase 3Janssen Research & Development, LLCNCT07225946Written as Prednisone/Prednisolone
- A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06925737Written as Prednisone
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)RecruitingPhase 3Merck Sharp & Dohme LLCNCT06136650Written as Prednisone acetate
- A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerRecruitingPhase 3BioNTech SENCT07365995Written as Prednisone/prednisolone
- Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary SarcoidosisNot yet recruitingPhase 2/3Peking Union Medical College HospitalNCT07668895Written as Prednisone
- Infliximab for Immune Checkpoint Inhibitor Associated AKIRecruitingPhase 4Massachusetts General HospitalNCT07683975Written as Prednisone
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerRecruitingPhase 3SWOG Cancer Research NetworkNCT03678025Written as Prednisone
- A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]RecruitingPhase 3GlaxoSmithKlineNCT07802704Written as Prednisone
- Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate CancerNot yet recruitingPhase 2/3ECOG-ACRIN Cancer Research GroupNCT07852195Written as Prednisone
- Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus ErythematosusNot yet recruitingPhase 2/3Chinese SLE Treatment And Research GroupNCT07814664Written as Prednisone Acetate Tablets
- Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)RecruitingPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT05942001Written as Prednisone Acetate Tablets
- A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)RecruitingPhase 2Medical University InnsbruckNCT07710157Written as Predniso(lo)ne
- BDB-001 Phase III Trial in ANCA-Associated VasculitisRecruitingPhase 3Staidson (Beijing) Biopharmaceuticals Co., LtdNCT07168161Written as Prednisone
- Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic TherapyRecruitingPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT06660355Written as Prednisone
- A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular LymphomaNot yet recruitingPhase 3Ruijin HospitalNCT07719855Written as Prednisone
- Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE TrialRecruitingPhase 2Mayo ClinicNCT06378866Written as Prednisone
- A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)RecruitingPhase 3CelgeneNCT06911502Written as Prednisone/Prednisolone
- Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapyRecruitingPhase 2University of BirminghamNCT05848765Written as Prednisone
- Taper Or Abrupt Steroid Stop: TOASSTtrialRecruitingPhase 4University Hospital, Basel, SwitzerlandNCT03153527Written as Prednisone
Showing 20 of 113.
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered3
- MK-2870-U01 Substudy 1: A Clinical Trial of Sacituzumab Tirumotecan to Treat Prostate Cancer (MK-2870-01A)Nov 2, 2026NCT07908524
- Efficacy and Safety of Polatuzumab Vedotin, Rituximab Combined With Reduced-dose Cyclophosphamide, Doxorubicin and Prednisone Regimen in the Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma: A Multicenter, Single-arm, Prospective StudyNov 2, 2026NCT07908888
- Molecular Evidence of Rejection Intervention TrialOct 29, 2026NCT07905599
Codes
What other systems call Prednisone · ClinicalTrials.gg INT008084
- MeSH (NLM) D011241PrednisoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) VB0R961HZTPREDNISONEConfirmed FDA, NLM, Wikidata
- RxNorm 8640Confirmed FDA, Wikidata
- Wikidata Q424972prednisoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C770PrednisoneOne source FDA
- DrugBank DB00635One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D011241 | Prednisone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | VB0R961HZT | PREDNISONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8640 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424972 | prednisone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C770 | Prednisone | One source FDA |
| DrugBank | DB00635 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.